Randomized phase II trial of liposomal cytarabine and daunorubicin with or without pomalidomide in newly diagnosed acute myeloid leukemia myelodysplasia-related.
- DOI
- 10.3324/haematol.2026.301466
- Published
- 2026 Sep 24
- Container
- Haematologica
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3324/haematol.2026.301466,
title = {Randomized phase II trial of liposomal cytarabine and daunorubicin with or without pomalidomide in newly diagnosed acute myeloid leukemia myelodysplasia-related.},
author = {Peters DT and Koenig K and Ivanova A and He J and Roboz GJ and Borate U and Gonzalez-Lugo J and Lin T and Powell B and Curran E and Hochman M and Reed D and Nichols A and Higgins L and McKinney A and Mims A and Carson W and Dees EC and Little RF and Streicher H and Hourigan C and Luznik L and Gojo I and Zeidner JF},
year = {2026},
journal = {Haematologica},
doi = {10.3324/haematol.2026.301466},
url = {https://doi.org/10.3324/haematol.2026.301466}
}RIS
TY - JOUR TI - Randomized phase II trial of liposomal cytarabine and daunorubicin with or without pomalidomide in newly diagnosed acute myeloid leukemia myelodysplasia-related. AU - Peters DT AU - Koenig K AU - Ivanova A AU - He J AU - Roboz GJ AU - Borate U AU - Gonzalez-Lugo J AU - Lin T AU - Powell B AU - Curran E AU - Hochman M AU - Reed D AU - Nichols A AU - Higgins L AU - McKinney A AU - Mims A AU - Carson W AU - Dees EC AU - Little RF AU - Streicher H AU - Hourigan C AU - Luznik L AU - Gojo I AU - Zeidner JF PY - 2026 JO - Haematologica DO - 10.3324/haematol.2026.301466 UR - https://doi.org/10.3324/haematol.2026.301466 ER -
APA
DT, P., K, K., A, I., J, H., GJ, R., U, B., J, G., T, L., B, P., E, C., M, H., D, R., A, N., L, H., A, M., A, M., W, C., EC, D., RF, L., H, S., C, H., L, L., I, G., & JF, Z. (2026). Randomized phase II trial of liposomal cytarabine and daunorubicin with or without pomalidomide in newly diagnosed acute myeloid leukemia myelodysplasia-related.. Haematologica. https://doi.org/10.3324/haematol.2026.301466